Developing and Validating a Machine Learning Model to Predict Brain Injury in Preterm Infants Using Multisource Data
Pu Xu1,2, Ying Li2, Ying Chen2
1Capital Institute of Pediatrics, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100020, China.
Children (Basel, Switzerland)
|June 26, 2026
Summary
A new machine learning model effectively predicts preterm brain injury (PBI) using routine clinical data, aiding early risk stratification for vulnerable infants and improving neurodevelopmental outcomes.
Area of Science:
- Neonatal neurology
- Machine learning in medicine
- Computational biology
Background:
- Moderate-to-severe preterm brain injury (PBI), including intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL), is a major cause of poor neurodevelopmental outcomes in preterm infants.
- Early identification of at-risk infants through risk stratification is crucial for timely intervention and improved outcomes.
Purpose of the Study:
- To develop and validate a machine learning model for early risk stratification of preterm brain injury (PBI).
- To identify key clinical predictors for PBI in preterm infants using routinely collected data.
Main Methods:
- Retrospective analysis of 318 preterm infants (development cohort) and 35 infants (external validation cohort).
- Evaluation of 33 candidate predictors from perinatal factors, early laboratory tests, and hospitalization data.
- Development and comparison of seven machine-learning algorithms, with LightGBM selected for final analysis.
- Nested cross-validation, Platt scaling for calibration, and assessment using AUROC, PR-AUC, and Brier score.
Main Results:
- The LightGBM model demonstrated moderate internal discrimination with an AUROC of 0.747.
- Key predictors included ventilation status and early physiological and laboratory indicators.
- Preliminary external validation showed a high AUROC (0.897), though with limitations due to small sample size and wide confidence intervals.
Conclusions:
- An interpretable LightGBM model was developed for PBI risk stratification using readily available early data.
- The model shows potential for clinical utility, with moderate internal performance and positive net benefit.
- Larger multicenter studies are necessary to confirm generalizability and refine the model for routine clinical implementation.

